Propanc Biopharma, Inc. (OTCMKTS:PPCB – Get Free Report) was up 108.3% during trading on Thursday . The stock traded as high as $145.46 and last traded at $25.00. Approximately 753 shares traded hands during mid-day trading, a decline of 100% from the average daily volume of 11,821,764 shares. The stock had previously closed at $12.00.
Propanc Biopharma Trading Up 108.3 %
The stock has a fifty day simple moving average of $0.50 and a two-hundred day simple moving average of $0.17.
About Propanc Biopharma
Propanc Biopharma, Inc, a biopharmaceutical company, develops cancer treatments for patients with pancreatic, ovarian, and colorectal cancer in Australia. It offers PRP, a formulation lead product that is in preclinical phase of development designed to enhance the anti-cancer effects of multiple enzymes.
Read More
- Five stocks we like better than Propanc Biopharma
- Investing in Travel Stocks Benefits
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- What is MarketRank™? How to Use it
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- What is a SEC Filing?
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Receive News & Ratings for Propanc Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Propanc Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
